ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » ARNA Stock Price » ARNA Stock News

Arena Share News

 Arena Pharmaceuticals (mm) Stock Price
ARNA Stock Price
 Arena Pharmaceuticals (mm) Stock Chart
ARNA Stock Chart
 Arena Pharmaceuticals (mm) Stock News
ARNA Stock News
 Arena Pharmaceuticals (mm) Company Information
ARNA Company Information
 Arena Pharmaceuticals (mm) Stock Trades
ARNA Stock Trades

Dow Drops After JP Morgan Trading Loss; Consumer Sentiment Rises

--Stocks end mostly lower as $2 billion J.P. Morgan trading loss dulls sentiment --Dow industrials post biggest weekly decline since mid-December following euro-zone concerns this week --Consumer sentiment unexpectedly rises By Matt Jarzemsky Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- The Dow industrials edged lower to cap their biggest weekly retreat of the year, as big trading losses at J.P. Morgan Chase weighed on sentiment. The Dow Jones Industrial Average fell 34.44 points, or 0.3%, to 12820.60, erasing earlier gains after reports of a Securities and Exchange Commission review tied to J.P. Morgan's trading loss. The blue-chip index fell 1.7% on the week, its worst weekly performance since mid-December. The Standard & Poor's 500-stock index retreated 4.6 points, or 0.3%, to 1353.39. The Nasdaq Composite rose 0.18 point, or less than 0.1%, to 2933.82. "We had a great first quarter and were up almost 30% from the lows in October, and now we're seeing a bit of a consolidation," said Jim Dunigan, managing executive of investments at PNC Wealth Management. "I don't know that we'll have a significant decline, but we may just drag along here." Financial shares led the S&P 500 lower as J.P. Morgan Chase fell $3.78, or 9.3%, to $36.96, its biggest percentage slide since August. The drop accounted for 83% of the Dow's decline. The blue-chip bank said late Thursday that it had taken $2 billion in trading losses in the past six weeks, stemming from bad derivatives bets. The company said it could face an additional $1 billion in losses in the second quarter as a result of market volatility. The news shaved $14.4 billion from J.P. Morgan's market value, as nearly 2.2 million shares in the bank changed hands, the most in a single day since at least 1984, according to FactSet Research Systems. Telecom shares advanced. Verizon Communications and AT&T rose, as Credit Suisse analysts recommended buying the shares, saying they will benefit from "growing discipline around pricing and subsidies in the wireless industry." Consumer sentiment improved in early May, according to a Thomson Reuters/University of Michigan index, bucking economists' expectations for a decline. The Producer Price Index was down 0.2% in April, while economists surveyed by Dow Jones Newswires were expecting a decline of 0.1%. The core PPI, which excludes food and energy, matched expectations with a rise of 0.2%. In Europe, the Stoxx Europe 600 added 0.3%, as the consumer-sentiment data and resilience in U.S. markets led a late rebound. Benchmark indexes in France and the U.K. fell for the second consecutive week, while the German DAX gained 1% on Friday and rose for the week. In Greece, Antonis Samaras, leader of the conservative New Democracy party, said he was able to find common ground with Democratic Left party leader Fotis Kouvelis, providing some hope that a coalition government will be formed. Also, the European Union said that while risks remain, it sees initial signs of an economic recovery in Europe next year. Asian markets fell, weighed down by J.P. Morgan Chase's news and some disappointing data out of China. Japan's Nikkei Stock Average and China's Shanghai Composite each shed 0.6%. Industrial output growth in China slowed in April to the lowest level since May 2009. Crude-oil prices lost 1%, to settle at $96.13, while gold prices declined 0.7%, to finish at $1,583.60 a troy ounce. The dollar rose against the yen but fell versus the euro. In corporate news, Nordstrom slumped 2.57, or 4.8%, to 50.96, after the high-end department-store chain reported fiscal first-quarter earnings that missed analyst expectations, but it affirmed its full-year outlook. Arena Pharmaceuticals rallied 2.70, or 74%, to 6.36 after a Food and Drug Administration panel recommended the approval of Arena's lorcaserin to treat obesity. Nvidia jumped 79 cents, or 6.4%, to 13.21 after the graphics-chip maker reported fiscal first-quarter results that were well above expectations and provided a second-quarter revenue outlook that was above projections. Ignite Restaurant Group, which operates the Joe's Crab Shack and Brick House Tavern+Tap chains, rose 3.13, or 22%, to 17.13 on its first day of trading. The company's initial public offering priced at $14, the high end of its expected range. -By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; matthew.jarzemsky@dowjones.com

Stock News for Arena (ARNA)
DateTimeHeadline
11/15/201309:18:03OZ Management LP 3Q 13F: Largest Purchases -2-
11/15/201309:18:02OZ Management LP 3Q 13F: Largest Purchases
11/15/201308:27:55S.A.C. Capital Advisors LP 3Q 13F: Largest Eliminations
11/15/201308:27:52S.A.C. Capital Advisors LP 3Q 13F: Largest -2-
11/15/201308:27:52S.A.C. Capital Advisors LP 3Q 13F: Largest Sales
11/15/201308:27:52S.A.C. Capital Advisors LP 3Q 13F: Largest Purchases
01/17/201309:20:44U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
01/07/201311:14:02Vivus's Free Promotion Lifts Prescriptions for Diet Drug
12/05/201215:02:25FDA Approves Highest Number of New Drugs Since 2004
07/19/201217:15:53Vivus Shares Drop Amid Report Questioning Diet Drug's Prospects
05/11/201217:25:10Dow Drops After JP Morgan Trading Loss; Consumer Sentiment Rises
03/26/201217:00:06US Stocks Erase Last Week's Losses; S&P Ends With Nearly Four-Year...
03/26/201209:12:54US STOCK FUTURES: HOT STOCKS TO WATCH
01/11/201209:09:45US Stock Futures: HOT STOCKS TO WATCH
01/10/201209:03:04Arena: FDA Accepts Resubmitted Application For Weight-Loss Drug...
11/22/201111:14:30Registration Effectiveness Orders Issued By The SEC
08/02/201107:29:39Arena, Eisai Diet Drug Less Concentrated In Human Brain Than...
02/17/201109:07:03Orexigen Financial Chief Cooper Resigns
02/10/201117:54:48Arena Pharma Finance Chief Hoffman To Leave Company
02/01/201116:14:46Diet Drug Decision Shows Why Drug Makers Have Kept Distance

Arena Pharmaceuticals and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad